News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
68,316 Results
Type
Article (2035)
Company Profile (22)
Press Release (66259)
Section
Business (31488)
Career Advice (49)
Deals (5094)
Drug Delivery (1)
Drug Development (8235)
Employer Resources (16)
FDA (1248)
Job Trends (1787)
News (43998)
Policy (2369)
Tag
Academia (133)
Academic (1)
Allergies (6)
Alliances (2521)
ALS (2)
Alzheimer's disease (130)
Antibody-drug conjugate (ADC) (13)
Approvals (1284)
Artificial intelligence (20)
Autoimmune disease (2)
Bankruptcy (19)
Best Places to Work (1670)
Biosimilars (7)
Biotechnology (17)
Bladder cancer (18)
Brain cancer (4)
Breast cancer (60)
Cancer (381)
Cardiovascular disease (27)
Career advice (44)
CAR-T (9)
CDC (1)
Cell therapy (34)
Cervical cancer (5)
Clinical research (7436)
Collaboration (59)
Compensation (31)
COVID-19 (149)
CRISPR (5)
C-suite (10)
Cystic fibrosis (12)
Data (495)
Depression (1)
Diabetes (25)
Diagnostics (659)
Digital health (3)
Diversity, equity & inclusion (4)
Drug discovery (12)
Drug pricing (6)
Duchenne muscular dystrophy (6)
Earnings (27999)
Employer branding (2)
Employer resources (13)
Events (7071)
Executive appointments (24)
FDA (1516)
Frontotemporal dementia (2)
Funding (53)
Gene editing (10)
Generative AI (3)
Gene therapy (39)
GLP-1 (82)
Government (275)
Guidances (113)
Healthcare (2182)
Huntington's disease (1)
IgA nephropathy (7)
Immunology and inflammation (12)
Immuno-oncology (1)
Indications (6)
Infectious disease (162)
Inflammatory bowel disease (16)
Inflation Reduction Act (1)
Influenza (4)
Intellectual property (4)
Interviews (7)
IPO (3916)
IRA (1)
Job creations (207)
Job search strategy (43)
Kidney cancer (4)
Labor market (6)
Layoffs (28)
Legal (451)
Liver cancer (9)
Lung cancer (61)
Lymphoma (30)
Machine learning (1)
Management (3)
Manufacturing (24)
MASH (13)
Medical device (1596)
Medtech (1596)
Mergers & acquisitions (1241)
Metabolic disorders (83)
Multiple sclerosis (19)
NASH (2)
Neurodegenerative disease (7)
Neuropsychiatric disorders (3)
Neuroscience (179)
NextGen: Class of 2025 (549)
Non-profit (281)
Now hiring (1)
Obesity (38)
Opinion (10)
Ovarian cancer (8)
Pain (6)
Pancreatic cancer (12)
Parkinson's disease (12)
Partnered (3)
Patents (19)
Patient recruitment (10)
Peanut (4)
People (2105)
Pharmaceutical (4)
Pharmacy benefit managers (1)
Phase I (1782)
Phase II (2974)
Phase III (3136)
Pipeline (645)
Policy (7)
Postmarket research (341)
Preclinical (568)
Press Release (1)
Prostate cancer (22)
Radiopharmaceuticals (21)
Rare diseases (51)
Real estate (291)
Recruiting (7)
Regulatory (1862)
Reports (11)
Research institute (156)
Resumes & cover letters (5)
Rett syndrome (2)
RNA editing (2)
RSV (5)
Schizophrenia (10)
Series A (7)
Series B (4)
Service/supplier (1)
Sickle cell disease (10)
Special edition (2)
Spinal muscular atrophy (6)
Startups (145)
Stomach cancer (4)
Supply chain (2)
Tariffs (3)
The Weekly (2)
Vaccines (83)
Weight loss (19)
Women's health (2)
Date
Last 7 days (40)
Last 30 days (164)
Last 365 days (4513)
2025 (2289)
2024 (5259)
2023 (5834)
2022 (6767)
2021 (7020)
2020 (6180)
2019 (4567)
2018 (3450)
2017 (3268)
2016 (2334)
2015 (3060)
2014 (2028)
2013 (1320)
2012 (1753)
2011 (2002)
2010 (1880)
Location
Africa (58)
Alabama (6)
Arizona (13)
Arkansas (2)
Asia (3498)
Australia (592)
California (996)
Canada (311)
China (61)
Colorado (51)
Connecticut (61)
Delaware (37)
Europe (9870)
Florida (124)
Georgia (43)
Idaho (3)
Illinois (60)
India (3)
Indiana (66)
Iowa (1)
Japan (23)
Kansas (8)
Kentucky (4)
Louisiana (4)
Maine (13)
Maryland (117)
Massachusetts (667)
Michigan (28)
Minnesota (55)
Missouri (8)
Montana (3)
Nebraska (3)
Nevada (6)
New Hampshire (9)
New Jersey (353)
New Mexico (1)
New York (305)
North Carolina (137)
Northern California (484)
Ohio (20)
Oregon (2)
Pennsylvania (205)
South America (88)
South Carolina (1)
Southern California (362)
Tennessee (18)
Texas (148)
United States (3635)
Utah (30)
Virginia (8)
Washington D.C. (5)
Washington State (117)
Wisconsin (5)
68,316 Results for "47".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lymphoma
Pfizer Ends Mid-Stage Trial for CD47 Blood Cancer Drug, Citing Recruitment Problems
Pfizer insists that the discontinuation of the Phase II study was due to recruitment difficulties and was not linked to maplirpacept’s safety or efficacy.
July 1, 2025
·
2 min read
·
Tristan Manalac
Press Releases
VenoValve to be Featured During Presentation at the 47th Annual Charing Cross Symposium
April 23, 2025
·
3 min read
Press Releases
BlackfinBio Announces FDA Clearance to Initiate Phase 1/2 Clinical Trial for Novel AAV Gene Therapy BFB-101 to Treat the Rare Neurological Disease Hereditary Spastic Paraplegia, Type 47 (SPG47)
April 28, 2025
·
4 min read
Press Releases
Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA)
June 9, 2025
·
3 min read
Press Releases
ImmuneOncia Announces Interim Results from Phase 1b Clinical Trial of Next-Generation CD47 Antibody ‘IMC-002' at ASCO 2025
June 2, 2025
·
3 min read
Press Releases
Ascletis Announces Positive Topline Results of Phase Ib Studies of ASC47 Monotherapy in Australia and U.S. FDA Clearance of IND Application for ASC47 in Combination with Semaglutide
March 12, 2025
·
6 min read
Press Releases
Bitterroot Bio Announces Dosing of First Patient in MATADOR Phase 2a Study of BRB-002, an Immunomodulating Therapy Targeting CD47 in Atherosclerotic Cardiovascular Disease
June 2, 2025
·
3 min read
Press Releases
Ethris Receives €10 Million EU4Health Grant to Support Clinical Development and Expand Antiviral Applications of Lead mRNA Candidate ETH47
May 6, 2025
·
4 min read
Press Releases
Ascletis Announces First Participants Dosed in a U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity
May 20, 2025
·
3 min read
Press Releases
Celltrion Receives EC Approval for Avtozma® (CT-P47), a Biosimilar to RoActemra® (tocilizumab)
February 24, 2025
·
6 min read
1 of 6,832
Next
